The antiquity of hydrocephalus: the first full palaeo-neuropathological description

The Pathology Museum of the University of Florence houses a rich collection of anatomical specimens and over a hundred waxworks portraying pathological conditions occurring in the nineteenth century, when the museum was established. Clinical and autopsy findings of these cases can still be retrieved from the original museum catalogue, offering a rare opportunity for retrospective palaeo-pathological diagnostics. We present a historical case of severe hydrocephalus backed by modern-day anthropological, radiological and molecular analyses conducted on the skeleton of an 18-month-old male infant deceased in 1831. Luigi Calamai (1796-1851), a wax craftsman of La Specola workshop in Florence, was commissioned to create a life-sized wax model of the child's head, neck and upper thorax. This artwork allows us to appreciate the cranial and facial alterations determined by 30 lb of cerebrospinal fluid (CSF) accumulated within the cerebral ventricular system. Based on the autopsy report, gross malformations of the neural tube, tumours and haemorrhage could be excluded. A molecular approach proved helpful in confirming sex. We present this case as the so-far most compelling case of hydrocephalus in palaeo-pathological research

Is panoramic radiography really a key examination before chemo-radiotherapy treatment for oropharyngeal cancer?

Aim: To evaluate the diagnostic accuracy of panoramic radiography (PAN) for the identification of infectious foci of the tooth and periradicular bone before definitive chemo-radiotherapy treatment for oropharyngeal cancer, using multislice spiral computed tomography (MSCT) imaging as the reference standard. Materials and methods: 50 patients with oropharyngeal cancer who had performed both pre-treatment MSCT and PAN were retrospectively evaluated. Pre-radiotherapy MSCT showed 65 deep caries, 37 root remnants, 143 stage III periodontal diseases, and 77 apical periodontitis, for a total of 322 infectious foci. The same number of healthy teeth (control group) was selected via MSCT to be analysed by PAN. Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy for PAN images with respect to MSCT imaging were examined. Results: PAN showed sensitivity, negative predictive value, and diagnostic accuracy of 100% for deep caries, root remnants, and stage III periodontal disease, whereas there were 46.8%, 64.7%, and 72.1% apical periodontitis respectively. Conclusions: PAN did not show great diagnostic accuracy in the assessment of apical periodontitis, and therefore maxillofacial MSCT carried out before chemo-radiotherapy treatment should always be examined to identify dental and jaw diseases. Deep caries, root remnants, and stage III periodontal disease were perfectly detected on PAN

Proposals for Innovation and Improvement of the Quality of Life in Caprine Pastoralist Communities of Subsistence in the Monte Desert, Argentina

In a satisfactory alliance between the main environmental policy organizations and the academy, the National Observatory on Land Degradation and Desertification (ONDTyT) is created. The ONDTyD provides information regarding status and trends of land degradation/desertification in order to promote prevention and mitigation measures used for advising public and private decision-makers in Argentina. It is based in the development of 17 Pilot Sites that constitutes the local level network, providing bio-physical and socio-economic indicators of land degradation. In this network the pilot site of the Monte, the largest dry region of Argentina (Lavalle desert, Mendoza), aims to improve the living conditions of native communities dedicated to subsistence goat farming, located below the poverty line. Precipitation ranges from 80-100 mm/year, strongly affecting productive activities. The proposal includes innovative traits in an area whose natural resources have been devastated. It is framed within a conception of rural territory development generating sustainable development strategies of rural indigenous communities, improve the status of the ecosystem through an integral management of natural and cultural resources, and improve socioeconomic conditions of inhabitants, compatibilizing ecosystem regeneration with investment in infrastructure and services, diversification of productive activities and generation of employment. An interdisciplinary group designed the proposal and the integrated desertification assessment in the fields with active community participation through their knowledge, land and livestock. The pilot case can be replicated throughout the territory. The work combines participatory and integrated methodologies, showing that the Observatory is a successful example of partnership building between the political and scientific-technological sectors in Argentina

Building the Embrapa rice breeding dataset for efficient data reuse.

Embrapa has led breeding programs for irrigated and upland rice (Oryza sativa L.) since 1977, generating a large amount of pedigree and phenotypic data. However, there were no systematic standards for data recording nor long-term data preservation and reuse strategies. With the new aim of making data reuse practical, we recovered all data available and structured it into the Embrapa Rice Breeding Dataset (ERBD). In its current version, the ERBD includes 20,504 crosses involving 9,974 parents, the pedigrees of most of the 4,532 inbred lines that took part in advanced field trials, and phenotypic data from 2,711 field trials (1,118 irrigated, 1,593 upland trials), representing 226,458 field plots. Those trials were conducted over 38 years (1982-2019), in 247 locations, in latitudes ranging from 3°N to 33°S. Phenotypic traits included grain yield, days to flowering, plant height, canopy lodging, and five important fungal diseases: leaf blast, panicle blast, brown spot, leaf scald, and grain discoloration. The total number of data points surpasses 1.27 million. Descriptive statistics were computed over the dataset, split by cropping systems (irrigated or upland). The mean heritability of grain yield was high for both systems, at around .7, whereas the mean coefficient of variation was 13.9% for irrigated trials and 18.7% for upland trials. The ERBD offers the possibility of conducting studies on different aspects of rice breeding and genetics, including genetic gain, G×E analysis, genome-wide association studies and genomic prediction

Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer

Introduction: In recent years, ovarian cancer (OC) treatment has been enriched with many new target therapies, most of all antiangiogenic drugs and PARP inhibitors (PARPis), which have literally changed the natural history of the disease. The impressive results of immunotherapy in other malignancies, mainly melanoma and lung cancer, and the good signals of activity in gynecological neoplasms like cervical and microsatellite instable (MSI-H) endometrial cancer, opened the space to the introduction of immune-stimulatory drugs in ovarian cancer. Area covered: The goal of this article is to summarize the newest evidence on the use of immune check point inhibitors in OC trying to explain why, at present, this strategy has failed to improve clinical outcome and focusing on the possible strategies to overcome treatment failure. Expert opinion: Although numerous trials have been undertaken, only scanty results have been obtained so far with immune check-point inhibitors (ICIs) in OC either when used as single agents or in combination with antiangiogenic therapy and ongoing trials are exploring the association of ICIs with PARPis and other ICIs. A better knowledge of predictive biomarkers of response and mechanisms of immunotherapy resistance, will help in identifying the most appropriate population to treat with ICIs

Newly diagnosed ovarian cancer: Which first-line treatment?

Poly ADP -Ribose Polymerase (PARP) inhibitors (PARPi) were firstly licensed for maintenance treatment in recurrent, platinum-sensitive, platinum responsive epithelial ovarian cancer patients, harboring or not a BRCA mutation. Three new phase III trials \u2013 PAOLA1/ENGOT-OV25, PRIMA/ENGOT-OV26 and VELIA/GOG-3005 \u2013 showed that there is a role for PARPi also in first-line setting, as maintenance or in combination with platinum-based chemotherapy. Nevertheless the published trials raised several questions on what is the best treatment according to the molecular and clinical characteristics of the treated patients. This review focuses on the published data in order to inform clinician decision making on what could be the best sequence or combination of treatments for the three molecular defined cohorts of patients emerging in the first line trials (the carriers of a BRCA mutation (BRCAmut), those with a deficiency in homologous recombination system (HRd) and those with a proficient homologous recombination system (HRp)) and put the newly published data in the context of the ovarian cancer treatment landscape